A Phase III, Open-Label Follow-on Study for Long-Term Safety and Efficacy of Testosterone Cream [ARD-0403; Ardana Bioscience], in Testosterone Deficient Men Completing Study ARD-0403-004
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2008
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Registrational; Therapeutic Use
- 31 Mar 2008 Status change from recruiting to discontinued, due to a company strategic decision. This information was taken from clinicaltrials.gov.
- 26 Nov 2007 New trial record.